Currently predicting for Thu, 4 Jun 2026

BLRX Prediction Chart

BLRX Predictions History

Latest community submissions for BLRX.
Predictor Target Session Target Price Result Direction Accuracy Score
Sep 7, 2023 $3.00 -96.94% $2.17 X 61.75% 0
Sep 1, 2023 Bullish $2.02 X 1
rleonid rleonid Amateur
Jul 27, 2021 $3.14 -97.59% $3.26 V 96.32% 0
rleonid rleonid Amateur
Jul 26, 2021 $3.32 -97.42% $3.22 X 96.89% 0
JS JS Pro
May 20, 2021 $3.04 -97.61% $3.18 X 95.60% 1
May 20, 2021 Bearish $3.18 V 0
JS JS Pro
Feb 19, 2021 $3.41 -97.44% $3.33 V 97.60% 1
JS JS Pro
Feb 16, 2021 $3.50 -97.36% $3.32 V 94.58% 1
Chris Chris @Chris.202009
Feb 16, 2021 Bearish $3.32 V 1
JS JS Pro
Feb 3, 2021 $3.01 -97.57% $3.10 X 97.10% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for BLRX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT BIOLINERX LTD.
BioLineRx
BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. The company develops Motixafortide, a peptide, which has completed Phase 3 clinical trials for the treatment of autologous stem cell mobilization and Phase 2a clinical trials for the treatment of pancreatic cancer; and that is in Phase 2 clinical trials for the treatment of metastatic pancreatic adenocarcinoma patients, and Phase 1b clinical trials in pat...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE